AGIO
Price
$36.07
Change
+$0.72 (+2.04%)
Updated
Jul 3 closing price
Capitalization
2.09B
26 days until earnings call
CRSP
Price
$52.17
Change
+$0.50 (+0.97%)
Updated
Jul 3 closing price
Capitalization
4.51B
37 days until earnings call
Interact to see
Advertisement

AGIO vs CRSP

Header iconAGIO vs CRSP Comparison
Open Charts AGIO vs CRSPBanner chart's image
Agios Pharmaceuticals
Price$36.07
Change+$0.72 (+2.04%)
Volume$258.71K
Capitalization2.09B
CRISPR Therapeutics AG
Price$52.17
Change+$0.50 (+0.97%)
Volume$1.84M
Capitalization4.51B
AGIO vs CRSP Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. CRSP commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (AGIO: $36.07 vs. CRSP: $52.17)
Brand notoriety: AGIO and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 46% vs. CRSP: 68%
Market capitalization -- AGIO: $2.09B vs. CRSP: $4.51B
AGIO [@Biotechnology] is valued at $2.09B. CRSP’s [@Biotechnology] market capitalization is $4.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 3 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • AGIO’s TA Score: 3 bullish, 5 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а +7.19% price change this week, while CRSP (@Biotechnology) price change was +11.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.51B) has a higher market cap than AGIO($2.09B). CRSP YTD gains are higher at: 32.546 vs. AGIO (9.769). AGIO (-434.71M) and CRSP (-455.24M) have comparable annual earnings (EBITDA) . CRSP has more cash in the bank: 1.86B vs. AGIO (893M). AGIO has less debt than CRSP: AGIO (52.9M) vs CRSP (219M). AGIO has higher revenues than CRSP: AGIO (37M) vs CRSP (35M).
AGIOCRSPAGIO / CRSP
Capitalization2.09B4.51B46%
EBITDA-434.71M-455.24M95%
Gain YTD9.76932.54630%
P/E Ratio3.13N/A-
Revenue37M35M106%
Total Cash893M1.86B48%
Total Debt52.9M219M24%
FUNDAMENTALS RATINGS
AGIO vs CRSP: Fundamental Ratings
AGIO
CRSP
OUTLOOK RATING
1..100
7047
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1794
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
7981
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is in the same range as CRSP (67). This means that AGIO’s stock grew similarly to CRSP’s over the last 12 months.

AGIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRSP (100). This means that AGIO’s stock grew similarly to CRSP’s over the last 12 months.

AGIO's SMR Rating (17) in the Biotechnology industry is significantly better than the same rating for CRSP (94). This means that AGIO’s stock grew significantly faster than CRSP’s over the last 12 months.

CRSP's Price Growth Rating (38) in the Biotechnology industry is in the same range as AGIO (46). This means that CRSP’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's P/E Growth Rating (79) in the Biotechnology industry is in the same range as CRSP (81). This means that AGIO’s stock grew similarly to CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOCRSP
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMBMX43.650.45
+1.04%
Principal MidCap R3
CVTRX52.330.47
+0.91%
Calamos Growth & Income A
JSVSX15.300.09
+0.59%
Janus Henderson Small-Mid Cap Value S
HFDYX19.430.11
+0.57%
Hartford Schroders US MidCap Opps Y
MDDLX10.450.05
+0.48%
MassMutual Diversified Value Adm

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with LGND. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+2.04%
LGND - AGIO
51%
Loosely correlated
+0.81%
ZYME - AGIO
49%
Loosely correlated
+1.16%
CRNX - AGIO
46%
Loosely correlated
+1.22%
VRDN - AGIO
46%
Loosely correlated
+2.89%
AXON - AGIO
45%
Loosely correlated
+2.70%
More